Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Outcome of Budd‐Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
- G. Zeitoun, S. Escolano, +9 authors Dominique Valla
- Medicine
- Hepatology
- 1 July 1999
The aim of this study was to assess the factors, including surgical portosystemic shunts, which affect survival in adults with Budd‐Chiari syndrome. Multivariate retrospective analysis was performed… Expand
Hepatic venous outflow block caused by short‐length hepatic vein stenoses
- D. Valla, A. Hadengue, +8 authors J. Benhamou
- Medicine
- Hepatology
- 1 April 1997
In contrast with the well‐recognized membranous obstruction of the inferior vena cava, short‐length hepatic vein stenoses are not well‐ recognized causes of hepatic venous outflow block. The aim of… Expand
High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma
- J. Gabarre, N. Azar, B. Autran, C. Katlama, V. Leblond
- Medicine
- The Lancet
- 25 March 2000
We describe the results of autologous haematopoietic stem-cell transplantation in eight patients with HIV-1-associated lymphoma. Collection and grafting of stem cells is feasible and this treatment… Expand
Severe autoimmune hemolytic anemia in eight patients treated with fludarabine.
- H. González, V. Leblond, +5 authors G. Dighiero
- Medicine
- Hematology and cell therapy
- 1 June 1998
We have used fludarabine to treat 36 patients with various lymphoid malignancies, including 29 with chronic lymphocytic leukemia (CLL). All these patients were heavily pretreated, and FAMP was… Expand
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
- J. Gabarre, A. Marcelin, +11 authors V. Leblond
- Medicine
- Haematologica
- 2004
BACKGROUND AND OBJECTIVES
The aim of this study was to assess the feasibility of high-dose chemotherapy plus autologous hematopoietic stem cell transplantation (HDC/AHSCT) in AIDS-related lymphoma… Expand
Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation
BACKGROUND: Allogeneic donor natural killer (NK)‐cell infusion (NK‐DLI) is a promising immunotherapy for patients with hematologic disorders.
Liver dysfunction in allogeneic bone marrow transplantation recipients.
- N. Azar, D. Valla, +7 authors V. Leblond
- Medicine
- Transplantation
- 15 July 1996
Liver dysfunction is common in allogeneic bone marrow graft recipients, but no systematic studies of pre- and posttransplantation liver biopsies have been performed to identify and compare hepatic… Expand
Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy
- C. Baillou, A. Simon, +5 authors F. Lemoine
- Medicine
- AIDS
- 7 March 2003
Objectives: To study, in asymptomatic HIV-1-infected (HIV+) patients, whether peripheral blood hematopoietic progenitor/stem cells (PBPC) mobilized by granulocyte colony stimulating factor (G-CSF),… Expand
Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience
- V. Lapierre, J. Rossi, +7 authors C. Chabannon
- Medicine
- Bone Marrow Transplantation
- 1 July 2011
Ancestim (r-MetHuSCF) is available in France for compassionate use in patients who are candidates for high-dose chemotherapy and autologous transplantation, and who failed in previous attempts at… Expand
Late Effects and Quality of Life
- B. Ranque-François, N. Boissel, +6 authors N. Dhédin
- Bone Marrow Transplantation
- 2002
Introduction. Age is commonly considered as a factor of failure in peripheral blood stem cells (PBSC) autologous transplantation. Therefore, this treatment is usually reserved to patients aged less… Expand